Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.
作者信息
Chen S D M, Lochhead J, Patel C K, Frith P
出版信息
Br J Ophthalmol. 2004 Jan;88(1):154-5. doi: 10.1136/bjo.88.1.154.
Abstract
摘要
相似文献
1
Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.
Br J Ophthalmol. 2004 Jan;88(1):154-5. doi: 10.1136/bjo.88.1.154.
2
Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Br J Ophthalmol. 2002 Feb;86(2):247-8. doi: 10.1136/bjo.86.2.247.
3
Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
Graefes Arch Clin Exp Ophthalmol. 2002 Sep;240(9):782-3. doi: 10.1007/s00417-002-0529-0. Epub 2002 Aug 13.
4
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Am J Ophthalmol. 2004 Mar;137(3):593-4; author reply 594. doi: 10.1016/j.ajo.2003.11.052.
5
Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Am J Ophthalmol. 2005 Jun;139(6):972-82. doi: 10.1016/j.ajo.2004.12.087.
6
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion.
Am J Ophthalmol. 2004 Mar;137(3):596; author reply 596-7. doi: 10.1016/j.ajo.2003.11.053.
7
Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Acta Ophthalmol Scand. 2005 Oct;83(5):600-4. doi: 10.1111/j.1600-0420.2005.00490.x.
8
Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Am J Ophthalmol. 2006 Oct;142(4):710; author reply 710. doi: 10.1016/j.ajo.2006.06.061.
9
Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
Eye (Lond). 2006 Jan;20(1):13-7. doi: 10.1038/sj.eye.6701803.
10
Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone.
Acta Ophthalmol Scand. 2006 Jun;84(3):314-8. doi: 10.1111/j.1600-0420.2005.00605.x.
引用本文的文献
1
Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan.
PLoS One. 2019 Dec 5;14(12):e0226118. doi: 10.1371/journal.pone.0226118. eCollection 2019.
2
Long-term efficacy and duration of action of dexamethasone implant, in vitrectomised and non-vitrectomised eyes with persistent diabetic macular oedema.
Eye (Lond). 2019 Mar;33(3):411-418. doi: 10.1038/s41433-018-0219-8. Epub 2018 Oct 9.
3
Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials.
Clin Ophthalmol. 2016 Mar 8;10:411-8. doi: 10.2147/OPTH.S98853. eCollection 2016.
4
The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion.
Clin Ophthalmol. 2014 Feb 7;8:355-62. doi: 10.2147/OPTH.S58468. eCollection 2014.
5
Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusion.
Clin Ophthalmol. 2013;7:39-45. doi: 10.2147/OPTH.S37185. Epub 2012 Dec 31.
6
Retinal sensitivity improvement after intravitreal triamcinolone acetonide injection for macular edema secondary to branch retinal vein occlusion.
Indian J Ophthalmol. 2013 Jan-Feb;61(1):3-7. doi: 10.4103/0301-4738.105048.
7
Hypothalamic-pituitary-adrenal axis function following intravitreal triamcinolone acetonide injection.
Int Ophthalmol. 2013 Apr;33(2):211-6. doi: 10.1007/s10792-012-9659-5. Epub 2012 Nov 7.
8
Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
Jpn J Ophthalmol. 2009 Sep;53(5):519-22. doi: 10.1007/s10384-009-0692-5. Epub 2009 Oct 22.
9
Use of intravitreal triamcinolone in the treatment of macular edema related to retinal vein occlusion.
Open Ophthalmol J. 2008 Apr 7;2:68-72. doi: 10.2174/1874364100802010068.
10
Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).
Trans Am Ophthalmol Soc. 2008;106:276-300.
本文引用的文献
1
Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema.
J Cataract Refract Surg. 2003 Jan;29(1):27-33. doi: 10.1016/s0886-3350(02)01441-4.
2
Intraocular pressure after intravitreal injection of triamcinolone acetonide.
Br J Ophthalmol. 2003 Jan;87(1):24-7. doi: 10.1136/bjo.87.1.24.
3
Intravitreal triamcinolone for refractory diabetic macular edema.
Ophthalmology. 2002 May;109(5):920-7. doi: 10.1016/s0161-6420(02)00975-2.
4
Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
Br J Ophthalmol. 2002 Feb;86(2):247-8. doi: 10.1136/bjo.86.2.247.
5
Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis.
Clin Exp Ophthalmol. 2001 Feb;29(1):2-6. doi: 10.1046/j.1442-9071.2001.00360.x.
6
Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration.
Clin Exp Immunol. 2000 Sep;121(3):458-65. doi: 10.1046/j.1365-2249.2000.01316.x.
7
Prognostic factors for retinal vein occlusion: prospective study of 175 cases.
Ophthalmology. 1996 Apr;103(4):551-60. doi: 10.1016/s0161-6420(96)30653-2.
8
Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group.
Am J Ophthalmol. 1984 Sep 15;98(3):271-82. doi: 10.1016/0002-9394(84)90316-7.
9
Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema.
Br J Ophthalmol. 1984 Mar;68(3):196-8. doi: 10.1136/bjo.68.3.196.
10
Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion.
Arch Ophthalmol. 1992 Oct;110(10):1427-34. doi: 10.1001/archopht.1992.01080220089028.
Zotero 插件